- Home
- CRVO vs NNY Comparison
CRVO vs NNY Comparison
Compare CRVO & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- NNY
- Stock Information
- Founded
- CRVO 2001
- NNY 1987
- Country
- CRVO United States
- NNY United States
- Employees
- CRVO N/A
- NNY N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- NNY Investment Managers
- Sector
- CRVO Health Care
- NNY Finance
- Exchange
- CRVO Nasdaq
- NNY Nasdaq
- Market Cap
- CRVO 160.4M
- NNY 163.0M
- IPO Year
- CRVO N/A
- NNY N/A
- Fundamental
- Price
- CRVO $14.05
- NNY $8.51
- Analyst Decision
- CRVO Strong Buy
- NNY
- Analyst Count
- CRVO 5
- NNY 0
- Target Price
- CRVO $57.60
- NNY N/A
- AVG Volume (30 Days)
- CRVO 79.1K
- NNY 50.9K
- Earning Date
- CRVO 11-11-2024
- NNY 01-01-0001
- Dividend Yield
- CRVO N/A
- NNY 4.04%
- EPS Growth
- CRVO N/A
- NNY N/A
- EPS
- CRVO N/A
- NNY N/A
- Revenue
- CRVO $9,653,281.00
- NNY N/A
- Revenue This Year
- CRVO $54.54
- NNY N/A
- Revenue Next Year
- CRVO N/A
- NNY N/A
- P/E Ratio
- CRVO N/A
- NNY N/A
- Revenue Growth
- CRVO 585.67
- NNY N/A
- 52 Week Low
- CRVO $5.85
- NNY $7.58
- 52 Week High
- CRVO $26.38
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- CRVO 47.39
- NNY 43.97
- Support Level
- CRVO $13.21
- NNY $8.47
- Resistance Level
- CRVO $14.79
- NNY $8.57
- Average True Range (ATR)
- CRVO 1.22
- NNY 0.06
- MACD
- CRVO 0.07
- NNY -0.01
- Stochastic Oscillator
- CRVO 60.14
- NNY 17.39
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing primarily in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.